Recombinant Anti-CD19 × Anti-CD3 Bispecific Antibody (Tandem Diabody). This bsAb has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm. The complex is capable of Retargeting of T cells to tumor. It was designed for the treatment of NHL and ALL.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
CROSS-L024 | Recombinant Anti-CD19 × Anti-CD3 Bispecific Antibody (CrossMab) | FuncS, Promising therapeutic agent | CrossMab |
There are currently no Customer reviews or questions for BSAB-L011. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.